InsightfulValue
← Home

Siemens Healthineers
Siemens Healthineers

-7.09%

Healthcare & biotech / Healthcare solutions and services


Press Releases

Date Press release
2025-05-01 02:00:00 More Impact, Together: Varian And Siemens Healthineers Portfolios Highlight More Impact, Innovations And More Breakthroughs Throughout Cancer Care Journey At Estro 2025
Palo alto, calif.--(business wire)--varian and siemens healthineers portfolios highlight more impact, innovations and more breakthroughs throughout cancer care journey at estro 2025.
2025-02-28 06:37:00 Siemens Healthineers And Vivolight Medical Collaborate To Launch Dsa-oct Integrated Multi-modal Diagnostic And Treatment Platform, Ushering In A New Era Of Intelligent Cath Labs
Shenzhen, china--(newsfile corp. - february 28, 2025) - recently, the world’s first dsa-oct integrated multi-modal diagnostic and treatment platform (artis icono floor), jointly developed by siemens healthineers and vivolight medical , has been officially installed at zhongshan hospital, affiliated with fudan university in shanghai, china. this marks a new era in the precision treatment of coronary heart disease.
2025-02-04 08:45:00 Siemens Healthineers Digital Transformation Strategies, Innovation Programs And Technology Initiatives
The report provides insights into siemens healthineers’ tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives. the report provides insights into siemens healthineers’ tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
2025-01-08 13:00:00 Inkspace Imaging Receives Fda 510(k) Clearance For 1.5t 24-channel Mr Coil For Siemens Healthineers
Pleasanton, calif., jan. 08, 2025 (globe newswire) -- inkspace imaging, a leader in mri coil innovation, today announced that the united states (us) food and drug administration (fda) has cleared inkspace imaging’s next-generation 1.5 tesla (1.5t) 24-channel mr coil for siemens healthineers magnetom mri scanners.
2024-12-02 07:30:00 Profound Medical And Siemens Healthineers To Offer A Complete Solution For Mri-guided Prostate Therapy
– combines profound’s tulsa-pro ® and siemens healthineers’ magnetom free.max – – supports the modern treatment pathway that allows for more accurate and precise diagnosis, treatment, and follow-up – – aligns well with cms 2025 final rule establishing urology apc level 7 reimbursement for tulsa procedure at all 3 sites of service – toronto, dec. 02, 2024 (globe newswire) -- profound medical corp. (nasdaq:prof; tsx:prn) (“profound” or the “company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that it has entered into a definitive co-sales and co-marketing agreement with siemens healthineers, a global leader in medical technology, pursuant to which the companies will commercialize a new mri-guided prostate therapy solution which combines profound’s tulsa-pro® system and consumables with siemens healthineers’ magnetom free.max magnetic resonance (“mr”) scanner.1 the transurethral ultrasound ablation (“tulsa”) procedure, performed using profound’s tulsa-pro® system, employs real-time mr guidance for precision to preserve prostate disease patients’ urinary continence and sexual function, while killing the targeted prostate tissue via a precise sound absorption technology that gently heats it to kill temperature (55-57°c). tulsa-pro® enables surgeons to ablate whole- or partial-gland prostate tissue in patients with low-, intermediate, or high-risk prostate cancer; with benign prostatic hyperplasia (“bph”); as well as those prostate cancer patients on active surveillance seeking treatment of their cancer and relief from their symptoms of bph.
Siemens Healthineers

Browse additional press releases for Siemens Healthineers!

Sign up for free or log in
© 2024 - 2025 InsightfulValue.com. All rights reserved. Legal